Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong

Objectives: Respiratory syncytial virus (RSV) is a leading cause of hospital admissions for acute respiratory infection among infants. A novel RSV prefusion F protein subunit (RSVpreF) vaccine has been recently approved in Hong Kong. The clinical and economic burden of RSV among infants in Hong Kong...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Victoria Wong, Michael Fung, Robyn Kendall, Luka Ivkovic, Amy W. Law, Diana Mendes
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Elsevier 2026-05-01
Cyfres:	International Journal of Infectious Diseases
Pynciau:	Cost-effectiveness Respiratory syncytial virus (RSV) RSVpreF vaccine Maternal immunization Hong Kong Bronchiolitis
Mynediad Ar-lein:	http://www.sciencedirect.com/science/article/pii/S1201971226001384
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!